The first epinephrine auto-injector built into the device you already carry. Because anaphylaxis can be fatal in minutes , and most people don't carry their injector.
Epinephrine is the first only treatment for anaphylaxis.
3.6 M Americans are prescribed an auto-injector every year. It's bulky. It's easy to forget , until the moment it matters.
of people prescribed an auto-injector don't carry it. The treatment exists. The device fails them.
Source · ACAAIAmericans have experienced anaphylaxis at least once in their life.
Every part inside was redesigned to fit a phone case , new geometry, simulated fluid dynamics, equivalent intramuscular dose.
11.4 mm thin, MagSafe-compatible. The thing you check 100 times a day now carries the thing that saves your life.
A single orange tab releases the injector. Press against the outer thigh to deliver 0.3 mg of epinephrine , the same therapeutic dose as a standard auto-injector.
A two-step release keeps it locked while it rides in your pocket or bag , it only fires when you mean it to. And the companion app flags , then locks out , a cartridge the moment it expires.
EpiSafe pairs with your phone over Bluetooth LE. See your device status in real time, keep a health profile ready for first responders, and try everything in Demo Mode before your device ships.
The market has been waiting for a new form factor. CAGR ~10% through 2030.
Every patient who carries or should be carrying epinephrine, globally.
33 M Americans live with potentially life-threatening food allergies , our serviceable U.S. market.
The 56% who already forget , the people we're built for.
Twenty-plus discovery interviews with R&D, regulatory, and quality leaders , and their feedback reshaped the product. See what changed →
Individuals from these companies shared their expertise during customer discovery , personal insight, not company endorsements.
Leave your email and we'll tell you the moment EpiSafe is available , plus the occasional build update.
A staged, roughly two-year path to FDA submission, nine months of product development behind us, patent pending, and a team that lives the problem every day.